Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  simvastatin
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-14 of 14 for your search:
Start Over
Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: Over 19
Sponsor: Other
Protocol IDs: 2009-11-017, NCT01238094
Safety of Simvastatin in LAM and TSC
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: The SOS Trial, NCT02061397
BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NCCCTS-10-489, BIBW 2992 1200.113, NCT01156545
Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NCCCTS-11-527, NCT01441349
Study of Metformin With Simvastatin for Men With Prostate Carcinoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H-28936, NCT01561482
Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: J13160, NA_00091900, NCT02096588
Simvastatin Effect on Radiation Therapy of Brain Metastases
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: PH CL 25, NCT02104193
Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients
Phase: Phase II
Type: Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: 2014-03-056, NCT02161822
Metformin and Simvastatin Use in Bladder Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 to 85
Sponsor: Other
Protocol IDs: MS_1, NCT02360618
Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC
Phase: Phase I
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D5160C00014, NCT02197234
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 29
Sponsor: Other
Protocol IDs: IRB00078790, NCT02390843
Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BCC-HEM-11-003, NCT01772719
Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer
Phase: No phase specified
Type: Prevention, Treatment
Status: Active
Age: 20 to 70
Sponsor: Other
Protocol IDs: 4-2012-0889, NCT01813994
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CASE8Y14, NCT02285738
Start Over